Literature DB >> 15147043

Establishment and characterization of a human malignant mesothelioma cell line (HMMME).

Isamu Ishiwata1, Chieko Ishiwata, Mitsuru Anzo, Rie Minami, Kazushige Kiguchi, Toshiaki Tachibana, Hiroshi Ishikawa.   

Abstract

A cell line designated "HMMME" was established from the pleural fluids of a malignant mesothelioma patient. This line grew well without interruption for 12 years and was subcultured over 200 times. The cells were spindle and roundish in shape and displayed a monolayer sheet in an epithelial pavement cell arrangement. They were neoplastic, had pleomorphic features, and easily formed multilayering without contact inhibition. The cell cytoplasm was strongly positive against anti-vimentin, anti-calretinin and anti-pan-keratin, but negative against anti-BerEP4. The cells proliferated rapidly, and the population doubling time was about 42 hours. Their chromosome number showed a wide distribution of aneuploidy with a mode in the diploid range; many marker chromosomes were observed. The cultured cells were easily transplanted into the subcutaneous of nude mice and produced a tumor classified as a malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15147043     DOI: 10.1111/j.1749-0774.2003.tb00157.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  13 in total

1.  Histochemical demonstration of hyaluronic acid in pleural mesotheliomas.

Authors:  J C WAGNER; D E MUNDAY; J S HARINGTON
Journal:  J Pathol Bacteriol       Date:  1962-07

2.  Manganese superoxide dismutase in human pleural mesothelioma cell lines.

Authors:  V L Kinnula; P Pietarinen-Runtti; K Raivio; K Kahlos; K Pelin; K Mattson; K Linnainmaa
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma.

Authors:  I Ishiwata; S Nozawa; T Inoue; H Okumura
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

4.  Calretinin: a novel immunocytochemical marker for mesothelioma.

Authors:  C Doglioni; A P Dei Tos; L Laurino; P Iuzzolino; C Chiarelli; M R Celio; G Viale
Journal:  Am J Surg Pathol       Date:  1996-09       Impact factor: 6.394

5.  Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis.

Authors:  A M Orengo; L Spoletini; A Procopio; R E Favoni; A De Cupis; A Ardizzoni; B Castagneto; M Ribotta; P G Betta; S Ferrini; L Mutti
Journal:  Eur Respir J       Date:  1999-03       Impact factor: 16.671

6.  Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining.

Authors:  H Kitazume; K Kitamura; K Mukai; Y Inayama; N Kawano; N Nakamura; J Sano; K Mitsui; S Yoshida; Y Nakatani
Journal:  Cancer       Date:  2000-02-25       Impact factor: 6.860

7.  Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.

Authors:  L S Manning; D Whitaker; A R Murch; M J Garlepp; M R Davis; A W Musk; B W Robinson
Journal:  Int J Cancer       Date:  1991-01-21       Impact factor: 7.396

8.  Establishment and preliminary characterization of human malignant mesothelioma cell lines.

Authors:  A de Cupis; P Pirani; R E Favoni
Journal:  Monaldi Arch Chest Dis       Date:  1998-04

9.  Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential.

Authors:  S M Hsu; P L Hsu; X Zhao; C S Kao-Shan; J Whang-Peng
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

10.  Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.

Authors:  J Klominek; K H Robért; A Hjerpe; B Wickström; G Gahrton
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  4 in total

1.  Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma.

Authors:  Kazushige Kiguchi; Isamu Ishiwata; Emiko Ishiwata; Yutaka Koshitaka; Tatsuru Ohara; Yoshiko Okudai; Sojiro Sato; Youichi Kobayashi; Bunpei Ishizuka; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

2.  Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line.

Authors:  Iwao Ishiwata; Emiko Ishiwata; Takashi Hirano
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

Review 3.  Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.

Authors:  Noushin Nabavi; Jingchao Wei; Dong Lin; Colin C Collins; Peter W Gout; Yuzhuo Wang
Journal:  Front Genet       Date:  2018-07-04       Impact factor: 4.599

Review 4.  Use of preclinical models for malignant pleural mesothelioma.

Authors:  Marie Shamseddin; Joanna Obacz; Mathew J Garnett; Robert Campbell Rintoul; Hayley Elizabeth Francies; Stefan John Marciniak
Journal:  Thorax       Date:  2021-03-10       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.